Physician profile
Daniel L Herkert
NPI 1922094879
$1,889.55
in general payments reported to CMS, 2019-2025
11 companies · $69.36 in 2025
The $69.36 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $38.73 · 2021: $71.90 · 2022: $429 · 2023: $377 · 2024: $87.82 · 2025: $69.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $703.68 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $443.68 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $229.68 | 2022-2025 | Infuse, Miebo, Blink Nutritears |
| Coopervision INC. | $175.04 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $127.36 | 2023 | Acuvue |
| Glaukos Corporation | $117.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $36.86 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $14.75 | 2025 | Acthar |
| Lkc Technologies, INC. | $14.71 | 2024 | |
| Allergan, INC. | $13.12 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $12.93 | 2023 | Clarus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Herkert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.